SP suggest a company heading towards BK.
It has actually done that but for raising the equity for Teva.
Otherwise it would have gone BK
WITH ALL THE FOOLISH DECISIONS.
However if it tineds over this period and still delivers Nuvaring generic and then E4,it can still
come out OK
like a casaerian section...
with lot of pain blood loss and scaring
Vs a normal deliveery.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)